In the Pioglitazone versus Vitamin E versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis (PIVENS) trial, for patients with NASH but without diabetes mellitus, the use of very high dosages of vitamin E (800 IU/day) for four years was associated with a significantly higher rate of improvement than placebo (43% vs. 19%) in the primary outcome.
Parkinson's disease | Alzheimer's disease | Centers for Disease Control and Prevention | Huntington's disease | Centers for Disease Control | Bright's disease | Alcoholic beverage | Dutch elm disease | disease | liver | Crohn's disease | Chagas disease | fatty acid | sexually transmitted disease | Plague (disease) | Chronic obstructive pulmonary disease | Sexually transmitted disease | Lyme disease | alcoholic beverage | liver cancer | Gaucher's disease | cardiovascular disease | Asbestos Disease Awareness Organization | Alzheimer's Disease | Paget's disease of bone | Motor Neurone Disease Association | Graves' disease | End stage renal disease | chronic obstructive pulmonary disease | Chronic kidney disease |